Steel Grove Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Steel Grove Capital Advisors's LLY Position: Q1 2026 in Review
Steel Grove Capital Advisors increased its Eli Lilly (LLY) stake by 8.1% in Q1 2026, buying an estimated $49.7K and bringing the position to 653 shares worth $601K. The position accounts for 0.06% of the portfolio, ranked #128.
Steel Grove Capital Advisors first reported a position in LLY in Q2 2013 and has held it in 28 quarters since. The position peaked at $4.88M in Q3 2014. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Steel Grove Capital Advisors held 653 shares of Eli Lilly worth $601K as of Q1 2026.
- Steel Grove Capital Advisors bought 49 Eli Lilly shares in Q1 2026, an estimated $49.7K.
- Eli Lilly made up 0.06% of Steel Grove Capital Advisors's portfolio in Q1 2026, its #128 holding.
- Steel Grove Capital Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 28 quarters since.
- Steel Grove Capital Advisors's Eli Lilly position peaked at $4.88M in Q3 2014.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Steel Grove Capital Advisors's 13F filing for Q1 2026, filed 7 May 2026.